Skip Navigation

Cardiovascular Research 2005 65(4):763-765; doi:10.1016/j.cardiores.2005.01.002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karliner, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karliner, J. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Symbols within words: Have we neglected the AdeNOsine A2 receptor?

Joel S. Karliner

Cardiology Section (111C), Veterans Affairs Medical Center and Department of Medicine University of California, San Francisco CA 94121, USA

joel.karliner@med.va.gov

Received 28 December 2004; accepted 4 January 2005

The first 10% of the full text of this article appears below.

See article by Xu et al. [10] (pages 803–812) in this issue.


   1. Adenosine and cardioprotection in patients: a crossroads?
 
Although considerable experimental effort has been expended during the past two decades in identifying mechanisms of cardioprotection, little of this work has been of direct benefit to patients. Thus, Bolli et al. have expressed concern that the field of myocardial protection is at a crossroads and have emphasized that there is an urgent need for the extensive experimental work in this area to be translated into clinically effective therapy [1]. The authors of this article, who represented a Working Group convened by the National Heart, Lung and Blood Institute, . . . [Full Text of this Article]


   2. Adenosine: a molecule skilled at multi-tasking
 

   3. Insights into mechanisms of adenosine A2 receptor agonism: what's new?
 

   4. Adenosine A2 receptor agonism: what we don't know
 

   5. Group therapy
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?